Dai-ichi Life Insurance Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.2M Buy
40,447
+344
+0.9% +$349K 1.07% 16
2025
Q4
$43.1M Buy
40,103
+215
+0.5% +$206K 1.11% 13
2025
Q3
$30.4M Sell
39,888
-5,839
-13% -$4.35M 0.76% 24
2025
Q2
$35.6M Buy
45,727
+5,421
+13% +$4.21M 1% 16
2025
Q1
$33.3M Sell
40,306
-1,231
-3% -$1.02M 0.97% 18
2024
Q4
$32.1M Sell
41,537
-563
-1% -$466K 0.89% 22
2024
Q3
$37.3M Sell
42,100
-13,714
-25% -$12.3M 0.94% 14
2024
Q2
$50.5M Sell
55,814
-1,565
-3% -$1.25M 1.23% 9
2024
Q1
$44.6M Sell
57,379
-15,347
-21% -$10.9M 1.01% 13
2023
Q4
$42.4M Sell
72,726
-42,830
-37% -$25M 0.88% 15
2023
Q3
$62.1M Sell
115,556
-8,525
-7% -$4.39M 1.37% 8
2023
Q2
$58.2M Sell
124,081
-18,988
-13% -$7.96M 1.21% 9
2023
Q1
$49.1M Buy
143,069
+8,885
+7% +$3M 1.08% 10
2022
Q4
$49.1M Buy
134,184
+33,647
+33% +$11.9M 1.14% 9
2022
Q3
$32.5M Buy
100,537
+13,419
+15% +$4.25M 0.8% 15
2022
Q2
$28.2M Sell
87,118
-63,684
-42% -$19.1M 0.63% 30
2022
Q1
$43.2M Sell
150,802
-8,000
-5% -$2.06M 0.69% 22
2021
Q4
$43.9M Sell
158,802
-11,827
-7% -$3M 0.56% 28
2021
Q3
$39.4M Sell
170,629
-18,173
-10% -$4.49M 0.51% 30
2021
Q2
$43.3M Buy
188,802
+41,408
+28% +$8.32M 0.54% 26
2021
Q1
$27.5M Sell
147,394
-21,579
-13% -$4.22M 0.38% 45
2020
Q4
$28.5M Buy
168,973
+38,446
+29% +$5.74M 0.41% 45
2020
Q3
$19.3M Buy
130,527
+21,507
+20% +$3.33M 0.35% 49
2020
Q2
$17.9M Sell
109,020
-11,575
-10% -$1.78M 0.41% 39
2020
Q1
$16.7M Sell
120,595
-81,404
-40% -$11.2M 0.64% 37
2019
Q4
$26.5M Sell
201,999
-14,529
-7% -$1.68M 0.6% 38
2019
Q3
$24.2M Buy
216,528
+21,057
+11% +$2.34M 0.58% 38
2019
Q2
$21.7M Buy
195,471
+116,027
+146% +$13.7M 0.53% 41
2019
Q1
$10.3M Sell
79,444
-4,253
-5% -$517K 0.25% 97
2018
Q4
$9.69M Buy
83,697
+18,812
+29% +$2.1M 0.26% 99
2018
Q3
$6.96M Hold
64,885
0.15% 145
2018
Q2
$5.54M Sell
64,885
-8,514
-12% -$699K 0.13% 160
2018
Q1
$5.68M Sell
73,399
-20,533
-22% -$1.65M 0.12% 171
2017
Q4
$7.93M Buy
93,932
+29,730
+46% +$2.53M 0.15% 133
2017
Q3
$5.49M Hold
64,202
0.12% 178
2017
Q2
$5.28M Buy
64,202
+7,376
+13% +$602K 0.12% 179
2017
Q1
$4.78M Sell
56,826
-159,441
-74% -$12.8M 0.13% 186
2016
Q4
$15.9M Buy
+216,267
New +$16.1M 0.47% 51

Other funds holding LLY

Dai-ichi Life Insurance Company's LLY Position: Q1 2026 in Review

Dai-ichi Life Insurance Company increased its Eli Lilly (LLY) stake by 0.86% in Q1 2026, buying an estimated $349K and bringing the position to 40,447 shares worth $37.2M. The position accounts for 1.07% of the portfolio, ranked #16.

Dai-ichi Life Insurance Company first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $62.1M in Q3 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dai-ichi Life Insurance Company held 40,447 shares of Eli Lilly worth $37.2M as of Q1 2026.
  • Dai-ichi Life Insurance Company bought 344 Eli Lilly shares in Q1 2026, an estimated $349K.
  • Eli Lilly made up 1.07% of Dai-ichi Life Insurance Company's portfolio in Q1 2026, its #16 holding.
  • Dai-ichi Life Insurance Company first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
  • Dai-ichi Life Insurance Company's Eli Lilly position peaked at $62.1M in Q3 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.